{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:45:30Z","timestamp":1790358330532,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ebiom.2017.08.024","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T10:01:53Z","timestamp":1504173713000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis"],"prefix":"10.1016","volume":"23","author":[{"given":"Liu","family":"Zhenjiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schoutrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"von Landenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingda","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Poiret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inti-Harvey","family":"Peredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Maeurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2017.08.024_bb0005","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ebiom.2017.08.024_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2017.08.024_bb0015","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/srep01870","article-title":"Mesothelin binding to CA125\/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation","volume":"3","author":"Chen","year":"2013","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2017.08.024_bb0020","doi-asserted-by":"crossref","first-page":"e1171445","DOI":"10.1080\/2162402X.2016.1171445","article-title":"IL-7 signaling imparts polyfunctionality and stemness potential to CD4(+) T cells","volume":"5","author":"Ding","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ebiom.2017.08.024_bb0025","first-page":"212","article-title":"Combining radiation therapy with immune checkpoint blockade for central nervous system malignancies","volume":"6","author":"D'Souza","year":"2016","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ebiom.2017.08.024_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2017.08.024_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02782192","article-title":"Long-term survival with metastatic cancer to the brain","volume":"17","author":"Hall","year":"2000","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ebiom.2017.08.024_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mcn.2012.10.004","article-title":"Role of the systemic immune system in brain metastasis","volume":"53","author":"Hamilton","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.ebiom.2017.08.024_bb0045","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2017.08.024_bb0050","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.ebiom.2017.08.024_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.pai.00000141545.36485.d6","article-title":"Localization of mesothelin in epithelial ovarian cancer","volume":"13","author":"Hassan","year":"2005","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"issue":"3","key":"10.1016\/j.ebiom.2017.08.024_bb0060","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","article-title":"Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy","volume":"68","author":"Hassan","year":"2010","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2017.08.024_bb0065","doi-asserted-by":"crossref","first-page":"e1122865","DOI":"10.1080\/2162402X.2015.1122865","article-title":"Harnessing the IL-7\/IL-7Ralpha axis to improve tumor immunotherapy","volume":"5","author":"Johnson","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ebiom.2017.08.024_bb0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-med-062315-120245","article-title":"CAR T cell therapy for solid tumors","volume":"68","author":"Newick","year":"2017","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.ebiom.2017.08.024_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","article-title":"Brain metastasis from ovarian cancer: a systematic review","volume":"119","author":"Pakneshan","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.ebiom.2017.08.024_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clbc.2013.05.001","article-title":"Mesothelin expression and survival outcomes in triple receptor negative breast cancer","volume":"13","author":"Parinyanitikul","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2017.08.024_bb0085","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1158\/0008-5472.CAN-14-0337","article-title":"Discovery of mesothelin and exploiting it as a target for immunotherapy","volume":"74","author":"Pastan","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ebiom.2017.08.024_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1006293606710","article-title":"Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas","volume":"45","author":"Quattrocchi","year":"1999","journal-title":"J. Neuro-Oncol."},{"issue":"12","key":"10.1016\/j.ebiom.2017.08.024_bb0095","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.4049\/jimmunol.1490019","article-title":"IL-2: the first effective immunotherapy for human cancer","volume":"192","author":"Rosenberg","year":"2014","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ebiom.2017.08.024_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CJI.0b013e318207ecfb","article-title":"Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded gammadeltaTcells: a phase I clinical study","volume":"34","author":"Sakamoto","year":"2011","journal-title":"J. Immunother."},{"issue":"3","key":"10.1016\/j.ebiom.2017.08.024_bb0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.5114\/aoms.2015.52362","article-title":"The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis","volume":"11","author":"Shen","year":"2015","journal-title":"Arch. Med. Sci."},{"issue":"1","key":"10.1016\/j.ebiom.2017.08.024_bb0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2013.09.018","article-title":"Abscopal effects of radiation therapy: a clinical review for the radiobiologist","volume":"356","author":"Siva","year":"2015","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ebiom.2017.08.024_bb0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.ebiom.2017.08.024_bb0120","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets","volume":"205","author":"Sportes","year":"2008","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.ebiom.2017.08.024_bb0125","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/1097-0142(19911201)68:11<2391::AID-CNCR2820681110>3.0.CO;2-7","article-title":"Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies. A preliminary report","volume":"68","author":"Takayama","year":"1991","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2017.08.024_bb0130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10549-012-2018-4","article-title":"Mesothelin, a novel immunotherapy target for triple negative breast cancer","volume":"133","author":"Tchou","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"13","key":"10.1016\/j.ebiom.2017.08.024_bb0135","doi-asserted-by":"crossref","first-page":"11694","DOI":"10.18632\/oncotarget.3429","article-title":"High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis","volume":"6","author":"Thomas","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.ebiom.2017.08.024_bb0140","first-page":"5241","article-title":"Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report","volume":"29","author":"Tomova","year":"2009","journal-title":"Anticancer Res."},{"issue":"12","key":"10.1016\/j.ebiom.2017.08.024_bb0145","doi-asserted-by":"crossref","first-page":"e114900","DOI":"10.1371\/journal.pone.0114900","article-title":"Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival","volume":"9","author":"Tozbikian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2017.08.024_bb0150","series-title":"Lyon: International Agency for Research on Cancer","first-page":"2014","author":"WHO. World Cancer Report","year":"2014"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417303419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417303419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T07:07:04Z","timestamp":1535440024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396417303419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"alternative-id":["S2352396417303419"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.08.024","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}